2009 (implants unavailable) | 2012 (subsidised implants available) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Total sample | Intrauterine methods* (total LARC) | Total sample | Intrauterine methods | Implant | Total LARC | |||||
Patient characteristics | n | n | % | n | n | % | n | % | n | % |
Total LARC use | 2771 | 968 | 34.9 | 2218 | 734 | 33.1 | 363 | 16.3 | 1097 | 49.5 |
Age-band (years) | ||||||||||
13–15 | 29 | 6 | 20.7 | 28 | 5 | 17.9 | 7 | 25.0 | 12 | 42.9 |
16–19 | 622 | 134 | 21.5 | 387 | 87 | 22.5 | 92 | 23.8 | 179 | 46.3 |
20–24 | 888 | 306 | 34.5 | 735 | 243 | 33.1 | 140 | 19.0 | 383 | 52.1 |
25–29 | 556 | 227 | 40.8 | 480 | 169 | 35.2 | 73 | 15.2 | 242 | 50.4 |
30–34 | 321 | 137 | 42.7 | 302 | 115 | 38.1 | 37 | 12.3 | 152 | 50.3 |
35–39 | 236 | 104 | 44.1 | 198 | 71 | 35.9 | 13 | 6.6 | 84 | 42.4 |
40+ | 119 | 54 | 45.4 | 88 | 44 | 50.0 | 1 | 1.1 | 45 | 51.1 |
Ethnic group | ||||||||||
NZ European | 1304 | 418 | 32.1 | 1075 | 345 | 32.1 | 155 | 14.4 | 500 | 46.5 |
NZ Maori | 796 | 300 | 37.7 | 658 | 207 | 31.5 | 155 | 23.6 | 362 | 55.0 |
Pacific | 311 | 122 | 39.2 | 256 | 105 | 41.0 | 41 | 16.0 | 146 | 57.0 |
Asian | 254 | 99 | 39.0 | 192 | 68 | 35.4 | 8 | 4.2 | 76 | 39.6 |
MELAA | 37 | 5 | 13.5 | 23 | 7 | 30.4 | 2 | 8.7 | 9 | 39.1 |
Not known/other | 69 | 24 | 34.8 | 14 | 2 | 14.3 | 2 | 14.3 | 4 | 28.6 |
SES/deprivation level† | ||||||||||
Dep 1–3 (least) | 516 | 178 | 34.5 | 421 | 140 | 33.3 | 48 | 11.4 | 188 | 44.7 |
Dep 4–7 (medium) | 1045 | 369 | 35.3 | 813 | 269 | 33.1 | 136 | 16.7 | 405 | 49.8 |
Dep 8–10 (most) | 1210 | 421 | 34.8 | 981 | 324 | 33.0 | 178 | 18.1 | 502 | 51.2 |
Abortion procedure | ||||||||||
Surgical | 2608 | 968 | 37.1 | 2119 | 734 | 34.6 | 363 | 17.1 | 1097 | 51.8 |
Medical | 163 | 0 | 0 | 101 | 0 | 0 | 0 | 0 | 0 | 0 |
Trimester | ||||||||||
First | 2589 | 952 | 36.8 | 2070 | 713 | 34.4 | 337 | 16.3 | 1050 | 50.7 |
Second | 182 | 16 | 8.8 | 148 | 21 | 14.2 | 26 | 17.6 | 47 | 31.8 |
Previous abortion(s) | ||||||||||
0 | 1696 | 521 | 30.7 | 1304 | 394 | 30.2 | 204 | 15.6 | 598 | 45.9 |
1 | 693 | 275 | 39.7 | 586 | 213 | 36.3 | 99 | 16.9 | 312 | 53.2 |
2 | 229 | 93 | 40.6 | 207 | 73 | 35.3 | 38 | 18.4 | 111 | 53.6 |
3+ | 153 | 79 | 51.6 | 121 | 54 | 44.6 | 22 | 18.2 | 76 | 62.8 |
Parity | ||||||||||
0 | 1446 | 344 | 23.8 | 1002 | 275 | 27.4 | 151 | 15.1 | 426 | 42.5 |
1 | 531 | 233 | 43.9 | 484 | 164 | 33.9 | 94 | 19.4 | 258 | 53.3 |
2 | 450 | 214 | 47.6 | 391 | 144 | 36.8 | 57 | 14.6 | 201 | 51.4 |
3+ | 344 | 177 | 51.5 | 341 | 151 | 44.3 | 61 | 17.9 | 212 | 62.2 |
Gravida | ||||||||||
1 | 1001 | 199 | 19.9 | 709 | 186 | 26.2 | 103 | 14.5 | 289 | 40.8 |
2 | 563 | 201 | 35.7 | 409 | 121 | 29.6 | 74 | 18.1 | 195 | 47.7 |
3+ | 1207 | 568 | 47.1 | 1100 | 427 | 38.8 | 186 | 16.9 | 613 | 55.7 |
*Includes copper intrauterine device and levonorgestrel intrauterine system.
†Three women had missing data on NZDep in 2012 (and were excluded only from this subsection of the table).
Dep, deprivation; LARC, long-acting reversible contraception; MELAA, Middle Eastern, Latin American/Hispanic, African; NZ, New Zealand; SES, socioeconomic status.